These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
57 related articles for article (PubMed ID: 1023978)
21. Priming but not boosting with plasmid DNA encoding mycolyl-transferase Ag85A from Mycobacterium tuberculosis increases the survival time of Mycobacterium bovis BCG vaccinated mice against low dose intravenous challenge with M. tuberculosis H37Rv. Romano M; D'Souza S; Adnet PY; Laali R; Jurion F; Palfliet K; Huygen K Vaccine; 2006 Apr; 24(16):3353-64. PubMed ID: 16488518 [TBL] [Abstract][Full Text] [Related]
22. The influence of remaining live BCG organisms in vaccinated mice on the maintenance of immunity to tuberculosis. Olsen AW; Brandt L; Agger EM; van Pinxteren LA; Andersen P Scand J Immunol; 2004 Sep; 60(3):273-7. PubMed ID: 15320884 [TBL] [Abstract][Full Text] [Related]
23. Fusion protein Ag85B-MPT64(190-198)-Mtb8.4 has higher immunogenicity than Ag85B with capacity to boost BCG-primed immunity against Mycobacterium tuberculosis in mice. Luo Y; Wang B; Hu L; Yu H; Da Z; Jiang W; Song N; Qie Y; Wang H; Tang Z; Xian Q; Zhang Y; Zhu B Vaccine; 2009 Oct; 27(44):6179-85. PubMed ID: 19712772 [TBL] [Abstract][Full Text] [Related]
24. Exposure to Mycobacterium avium can modulate established immunity against Mycobacterium tuberculosis infection generated by Mycobacterium bovis BCG vaccination. Flaherty DK; Vesosky B; Beamer GL; Stromberg P; Turner J J Leukoc Biol; 2006 Dec; 80(6):1262-71. PubMed ID: 16968819 [TBL] [Abstract][Full Text] [Related]
25. [The genetic regulation of host response to inoculation with Mycobacterium bovis (BCG) and Mycobacterium tuberculosis H37RV]. Nikonenko BV; Mezhlumova MB; Moroz AM Biull Eksp Biol Med; 1990 Nov; 110(11):526-8. PubMed ID: 2128037 [TBL] [Abstract][Full Text] [Related]
26. Idiopathic paraproteinemia. III. Increased frequency of paraproteinemia in thymectomized aging C57BL/KaLwRij and CBA/BrARij mice. Radl J; de Glopper E; van den Berg P; van Zwieten MJ J Immunol; 1980 Jul; 125(1):31-5. PubMed ID: 6769998 [TBL] [Abstract][Full Text] [Related]
27. Cellular mechanisms of genetically controlled host resistance to Mycobacterium bovis (BCG). Gros P; Skamene E; Forget A J Immunol; 1983 Oct; 131(4):1966-72. PubMed ID: 6311901 [TBL] [Abstract][Full Text] [Related]
28. Schistosoma mansoni infection reduces the protective efficacy of BCG vaccination against virulent Mycobacterium tuberculosis. Elias D; Akuffo H; Pawlowski A; Haile M; Schön T; Britton S Vaccine; 2005 Feb; 23(11):1326-34. PubMed ID: 15661380 [TBL] [Abstract][Full Text] [Related]
29. [Increased delayed type hypersensitivity and immunity to tuberculosis]. Averbakh MM; Gergert VIa; Kliuev VA; Kolodiazhnaia NS; Litvinov VI Probl Tuberk; 1972; 50(6):60-4. PubMed ID: 5051130 [No Abstract] [Full Text] [Related]
30. Protection against an aerogenic Mycobacterium tuberculosis infection in BCG-immunized and DNA-vaccinated mice is associated with early type I cytokine responses. Goter-Robinson C; Derrick SC; Yang AL; Jeon BY; Morris SL Vaccine; 2006 Apr; 24(17):3522-9. PubMed ID: 16519971 [TBL] [Abstract][Full Text] [Related]
31. Potential correlates of BCG induced protection against tuberculosis detected in a mouse aerosol model using gene expression profiling. Rodgers A; Whitmore KM; Walker KB Tuberculosis (Edinb); 2006; 86(3-4):255-62. PubMed ID: 16600686 [TBL] [Abstract][Full Text] [Related]
32. Cellular regulation of lung granuloma formation and delayed- type hypersensitivity induced with BCG cell walls. Further evidence of involvement of cellular immunity in lung granuloma formation. Yamamoto K; Kato K; Kakinuma M; Brehmer W Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Mar; 251(3):357-68. PubMed ID: 7043952 [TBL] [Abstract][Full Text] [Related]
33. The effect of neonatal and adult thymectomy on the inflammatory response. Rothwell TL; Spector WG J Pathol; 1972 Sep; 108(1):15-21. PubMed ID: 4346269 [No Abstract] [Full Text] [Related]
34. Protection against tuberculosis induced by oral prime with Mycobacterium bovis BCG and intranasal subunit boost based on the vaccine candidate Ag85B-ESAT-6 does not correlate with circulating IFN-gamma producing T-cells. Badell E; Nicolle F; Clark S; Majlessi L; Boudou F; Martino A; Castello-Branco L; Leclerc C; Lewis DJ; Marsh PD; Gicquel B; Winter N Vaccine; 2009 Jan; 27(1):28-37. PubMed ID: 18977269 [TBL] [Abstract][Full Text] [Related]
35. Various strains of BCG vaccine and genetic control of the immune response of mice. Lagrange PH; Hurtrel B; Brandely M; Stach JL Dev Biol Stand; 1986; 58 ( Pt A)():25-36. PubMed ID: 3109987 [TBL] [Abstract][Full Text] [Related]
36. Strain differences in mouse cellular responses to Mycobacterium lepraemurium and BCG subcutaneous infections. I. Analysis of cell surface phenotype in local granulomas. Roch F; Bach MA Clin Exp Immunol; 1990 Jun; 80(3):332-8. PubMed ID: 2197047 [TBL] [Abstract][Full Text] [Related]
38. Role of the thymus in control of autoreactivity or allotolerance in syngeneic and allogeneic bone marrow chimeras treated with bacterial adjuvants. Taniguchi K; Gondo H; Nomoto K J Immunol; 1984 Oct; 133(4):1735-9. PubMed ID: 6088626 [TBL] [Abstract][Full Text] [Related]
39. [Regulation of antitubercular immunity in mice by genes of the H-2 complex]. AptAS ; Nikonenko BV; Moroz AM; Averbakh MM Biull Eksp Biol Med; 1988 Jul; 106(7):73-5. PubMed ID: 3401584 [TBL] [Abstract][Full Text] [Related]